Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 47% ± 22% | |
lung | 10 studies | 30% ± 10% | |
eye | 8 studies | 42% ± 20% | |
heart | 5 studies | 31% ± 8% | |
peripheral blood | 4 studies | 26% ± 6% | |
kidney | 4 studies | 26% ± 8% | |
intestine | 4 studies | 20% ± 5% | |
liver | 3 studies | 36% ± 17% | |
adipose | 3 studies | 31% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5090.47 | 1445 / 1445 | 100% | 24.63 | 183 / 183 |
prostate | 100% | 6669.99 | 245 / 245 | 100% | 28.55 | 501 / 502 |
lung | 100% | 6042.89 | 578 / 578 | 100% | 19.08 | 1152 / 1155 |
breast | 100% | 6222.43 | 459 / 459 | 100% | 29.23 | 1115 / 1118 |
brain | 100% | 4063.61 | 2634 / 2642 | 100% | 22.00 | 705 / 705 |
bladder | 100% | 5107.81 | 21 / 21 | 100% | 21.73 | 502 / 504 |
pancreas | 100% | 2732.90 | 328 / 328 | 99% | 20.50 | 177 / 178 |
thymus | 100% | 6910.29 | 653 / 653 | 99% | 21.02 | 601 / 605 |
ovary | 100% | 6793.47 | 180 / 180 | 99% | 14.49 | 426 / 430 |
uterus | 100% | 6124.86 | 170 / 170 | 98% | 19.97 | 452 / 459 |
intestine | 100% | 5779.17 | 966 / 966 | 98% | 20.20 | 517 / 527 |
stomach | 100% | 4377.03 | 359 / 359 | 97% | 20.11 | 278 / 286 |
adrenal gland | 100% | 5787.14 | 258 / 258 | 97% | 19.25 | 223 / 230 |
kidney | 100% | 4031.53 | 89 / 89 | 95% | 14.58 | 860 / 901 |
skin | 100% | 6074.92 | 1809 / 1809 | 91% | 16.80 | 431 / 472 |
liver | 100% | 2416.36 | 226 / 226 | 69% | 6.18 | 279 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.70 | 29 / 29 |
spleen | 100% | 6303.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.55 | 1 / 1 |
blood vessel | 100% | 5196.81 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 5552.19 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 3418.57 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 3476.67 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 3362.15 | 811 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 9.10 | 63 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0008150 | Biological process | biological_process |
GO_0005829 | Cellular component | cytosol |
GO_0016605 | Cellular component | PML body |
GO_0005634 | Cellular component | nucleus |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ZMYM2 |
Protein name | Zinc finger MYM-type containing 2 Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198) |
Synonyms | ZNF198 RAMP FIM |
Description | FUNCTION: Involved in the negative regulation of transcription. . |
Accessions | Q9UBW7 ENST00000382871.3 [Q9UBW7-1] ENST00000382874.6 [Q9UBW7-1] A0A087X151 ENST00000620447.1 ENST00000610343.5 [Q9UBW7-1] |